NEW YORK (GenomeWeb News) – Molecular diagnostics is gaining traction among clinicians and were the second-most popular type of test performed in the second quarter, according to a survey released today by investment bank Mizuho Securities.

In the survey of 262 physicians and laboratory personnel for clues about trends in clinical labs, Mizuho found that molecular testing made up 25 percent of all tests performed during the second quarter of this year, trailing only immunochemical tests, which made up 36 percent of all test conducted.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.